Aileron Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Aileron Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2018 to Q3 2024.
  • Aileron Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -27.9 %, a 64.4% increase year-over-year.
  • Aileron Therapeutics, Inc. annual Return On Assets for 2023 was -42 %, a 52.7% increase from 2022.
  • Aileron Therapeutics, Inc. annual Return On Assets for 2022 was -88.7 %, a 93.6% decline from 2021.
  • Aileron Therapeutics, Inc. annual Return On Assets for 2021 was -45.8 %, a 64.3% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -27.9 +50.5 +64.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -30.8 +56.2 +64.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -31.2 +63.4 +67.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -42 +46.7 +52.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -78.5 +0.57 +0.72% Jul 1, 2023 Sep 30, 2023
Q2 2023 -87 -19.5 -28.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -94.6 -40.5 -74.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -88.7 -42.9 -93.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -79 -29.5 -59.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -67.5 -12.3 -22.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -54.1 +11.8 +17.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -45.8 +53.4 +53.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -49.5 +48.8 +49.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -55.2 +42.5 +43.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -65.9 +29.7 +31% Jan 1, 2021 Mar 31, 2021
Q4 2020 -99.2 -3.67 -3.84% Oct 1, 2020 Dec 31, 2020
Q3 2020 -98.3 -6.33 -6.88% Jul 1, 2020 Sep 30, 2020
Q2 2020 -97.7 -9.65 -11% Apr 1, 2020 Jun 30, 2020
Q1 2020 -95.6 -2.11 -2.26% Jan 1, 2020 Mar 31, 2020
Q4 2019 -95.5 -15.1 -18.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 -92 -21.9 -31.3% Jul 1, 2019 Sep 30, 2019
Q2 2019 -88.1 -27.7 -45.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 -93.5 -34.1 -57.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -80.5 Oct 1, 2018 Dec 31, 2018
Q3 2018 -70 Jul 1, 2018 Sep 30, 2018
Q2 2018 -60.4 Apr 1, 2018 Jun 30, 2018
Q1 2018 -59.4 Jan 1, 2018 Mar 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.